Skip to main content
Clinical Trials/NCT03971292
NCT03971292
Unknown
Not Applicable

Interest of High-throughput Sequencing of RNAs for the Diagnosis of Heterogeneous Genetic Diseases

University Hospital, Strasbourg, France1 site in 1 country15 target enrollmentJune 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
DNA Sequencing
Sponsor
University Hospital, Strasbourg, France
Enrollment
15
Locations
1
Primary Endpoint
RNA sequencing
Last Updated
6 years ago

Overview

Brief Summary

The advent of high throughput genomic DNA sequencing has led to major advances in the diagnosis of genetic diseases of heterogeneous origin. Thus, our hospital laboratory has developed in recent years several diagnostic tests based on the targeted sequencing of coding sequences of gene panels (from about twenty genes for DNA repair diseases to nearly five hundred genes for the intellectual disability). These targeted analyzes, carried out by capture, have thus solved 25 to 80% of the cases according to the indications, without allowing the diagnosis of the totality of the patients.

For these negative cases, the search for mutations in the coding sequences was then extended to Whole Exome Sequencing, thus providing several additional diagnoses.

Patients still remain without diagnosis after this exome study. These could be complex cases of genetic or even non-genetic origin, but also monogenic pathologies linked to mutations that are not identifiable by coding sequence analyzes, and especially affecting messenger RNAs.

Registry
clinicaltrials.gov
Start Date
June 2019
End Date
July 2022
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

RNA sequencing

Time Frame: 3 years

testing interest of messenger RNA sequencing for the etiological diagnosis of unresolved patients after sequencing of coding regions, and its integration into hospital routine in order to improve the diagnosis of heterogeneous genetic diseases.

Study Sites (1)

Loading locations...

Similar Trials